FIGURE 1.

Study design. *Four hundred thirty-seven PSPs enrolled, and 430 received CAB + RPV LA. ^†Dose 1 was received at month 1, dose 2 at month 2, with the remaining doses Q2M thereafter. ^‡Introduce CAB + RPV LA to clinic staff and discuss what might make implementation easier and/or what might make it difficult before the first injection at the site. Meetings discussed implementation plans, how to work through challenges, and how to introduce continuous quality improvement. Arm-E, enhanced implementation arm; Arm-S, standard implementation arm; CQI, continuous quality improvement; MSL, medical scientific liaison; OLI, oral lead-in; SWAT, skilled wrap-around team.